Ductal Carcinoma In Situ and Microinvasive/Borderline Breast Cancer

Lisa A. Newman, MD, MPH, FACS Professor of Surgery, Director, Breast Care Center, University of Michigan Health System, Comprehensive Cancer Center, Ann Arbor, MI, USA Jessica M. Bensenhaver, MD Assistant Professor of Surgery, University of Michigan Health System, Comprehensive Cancer Center, Ann Arbor, MI, USA

Epidemiology of Ductal Carcinoma In Situ.- Role of Screening Mammography in Early Detection/Outcome from Breast Cancer.- Imaging DCIS: Digital/Film Screening Mammography, Tomosynthesis, MRI, Ultrasonography.- Pathology of Ductal Carcinoma In Situ: Features and Diagnostic Challenges.- Molecular Markers in DCIS.- History of Ductal Carcinoma In Situ Management Based Upon Data from Prospective, Randomized Clinical Trials.- Extent and Role of Margin Control for DCIS Managed by Breast-Conserving Surgery.- Ductal Carcinoma In Situ Treated With Breast Conserving Surgery Alone.- DCIS Managed with BCS: Whole-Breast XRT vs. Partial Breast XRT.- Anti-HER2/neu Therapy in DCIS.- Role of Genetic Profiling and Recurrence Scores in Treatment Planning for DCIS.- DCIS and Sentinel Lymph Node Biopsy.- Role of Postmastectomy Radiation for DCIS.- Monitoring and Surveillance Following DCIS Treatment.- DCIS and Hereditary Susceptibility for Breast Cancer.- Introduction, Evolution and Application of the Van Nuys Prognostic Index in DCIS.- Disparities in DCIS Detection and Outcomes Related to Race/Ethnicity.